Abstract: The invention relates to a device for applying a marking to the human eye, in particular on the cornea, comprising a marking head (1) and a retaining device (2) that supports the marking head (1), wherein the marking head (1) comprises a marking element (4) and a support that retains the marking element (4) in a specifiable or changeable angular position, wherein the support is arranged in a rotationally fixed manner relative to the retaining device (2) or a reference line and wherein the marking head (1) can be detached from the retaining device (2).

Abstract: The invention relates to a device for applying a marking to the human eye, in particular on the cornea, comprising a marking head (1) and a retaining device (2) that supports the marking head (1), wherein the marking head (1) comprises a marking element (4) and a support that retains the marking element (4) in a specifiable or changeable angular position, wherein the support is arranged in a rotationally fixed manner relative to the retaining device (2) or a reference line and wherein the marking head (1) can be detached from the retaining device (2).

Abstract: The invention relates to a template for placing on an eye, said template having a circular concavity on one side. The invention also relates to a template with a massage device and to a film for placing on an eye. The invention further relates to a method for producing such a template and to a use of such a template.

Abstract: According to the invention, a novel ophthalmic medicament is made available, which contains in aqueous solution or suspension at least one carbohydrate, at least one amino acid, at least one electrolyte, a chondroitin sulfate and optionally further customary excipients.

Abstract: According to the invention, a novel ophthalmic medicament is made available, which contains in aqueous solution or suspension at least one carbohydrate, at least one amino acid, at least one electrolyte, a chondroitin sulfate and optionally further customary excipients.

Abstract: An intra-ocular lens can be implanted as a posterior chamber lens by way of its lens body in a capsule sack remaining in the eye after an extracapsular operation. An equatorial edge of the lens body has a surrounding concave profile which is open to the outside and is bounded by two profile edges. At least one of the profile edges acts as a mechanical barrier against fibrosis on the rear capsule.